David C Smith

A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors

Branimir Sikic, David C. Smith, Rashmi Chugh, 2014, Clinical Cancer Research.

Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer.

Ming Zhao, David C. Smith, Janet Mendonca, 2013, The oncologist.

The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminoma.

Mohammed U Kabeto, David C. Smith, H. Sandler, 2002, International Journal of Radiation Oncology, Biology, Physics.

Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.

Bruce Montgomery, Javed Siddiqui, Walter M Stadler, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)

Walter M Stadler, David C. Smith, Roberto Pili, 2009, Cancer.

Ordered mesoporous silica films with pores oriented perpendicular to a titanium nitride substrate.

Richard Beanland, Alain Walcarius, S. Boden, 2015, Physical chemistry chemical physics : PCCP.